GLIMICEF M1

Composition:

• Active Ingredients:

  • Glimepiride: 1 mg

  • Metformin Hydrochloride (Extended-Release): 500 mg

Formulation:

• Form: Tablet

• Dosage Strength:

  • 1 mg of Glimepiride

  • 500 mg of Metformin Hydrochloride (ER)

• Route of Administration: Oral

Status:

• Prescription Status: Prescription-only medication (Rx)

• Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for the treatment of type 2 diabetes mellitus.

Benefits:

• Blood Sugar Control in Type 2 Diabetes:

  • Glimepiride: A sulfonylurea that helps lower blood sugar by stimulating the release of insulin from the pancreas. It is effective in reducing fasting and postprandial (after meal) blood glucose levels.

  • Metformin Hydrochloride (ER): A biguanide that works by decreasing glucose production in the liver, improving insulin sensitivity, and enhancing glucose uptake by the muscles. The extended-release formulation allows for gradual release, improving tolerability and reducing gastrointestinal side effects.

• Dual Mechanism: The combination of Glimepiride and Metformin offers a synergistic effect in controlling blood sugar levels, making it an effective option for managing type 2 diabetes in patients who require multiple mechanisms of action.

• Prevention of Diabetes Complications: Effective blood sugar management helps reduce the risk of diabetes-related complications, such as neuropathy, nephropathy, and retinopathy.

• Improved Patient Compliance: The combination of two antidiabetic agents in a single tablet simplifies the treatment regimen, which can lead to better adherence and overall control of diabetes.